Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$402K Sell
3,125
-31,678
-91% -$3.71M 0.01% 2655
2026
Q1
$4.19M Buy
+34,803
New +$4.02M 0.07% 373
2025
Q4
Sell
-39,536
Closed -$3.32M 3620
2025
Q3
$3.32M Buy
+39,536
New +$3.26M 0.17% 86
2025
Q2
Sell
-25,325
Closed -$2.27M 2877
2025
Q1
$2.27M Buy
25,325
+15,404
+155% +$1.44M 0.12% 214
2024
Q4
$987K Sell
9,921
-31,228
-76% -$3.22M 0.08% 312
2024
Q3
$4.67M Buy
41,149
+2,977
+8% +$354K 0.34% 17
2024
Q2
$4.73M Buy
38,172
+28,997
+316% +$3.74M 0.4% 10
2024
Q1
$1.21M Buy
9,175
+6,838
+293% +$843K 0.16% 109
2023
Q4
$255K Sell
2,337
-774
-25% -$80.3K 0.06% 761
2023
Q3
$320K Buy
+3,111
New +$335K 0.05% 684
2023
Q1
Sell
-12,136
Closed -$1.35M 1523
2022
Q4
$1.35M Buy
+12,136
New +$1.24M 0.29% 43
2022
Q1
Sell
-5,772
Closed -$442K 854
2021
Q4
$442K Sell
5,772
-21,718
-79% -$1.73M 0.25% 95
2021
Q3
$2.06M Buy
+27,490
New +$2.09M 0.69% 10
2021
Q2
Sell
-7,704
Closed -$567K 987
2021
Q1
$567K Buy
+7,704
New +$568K 0.28% 63

Other funds holding MRK

XTX Topco's MRK Position: Q2 2026 in Review

XTX Topco reduced its Merck (MRK) stake by 91% in Q2 2026, selling an estimated $3.71M and leaving 3,125 shares worth $402K. The position accounts for 0.01% of the portfolio, ranked #2655.

XTX Topco first reported a position in MRK in Q1 2021 and has held it in 14 quarters since. The position peaked at $4.73M in Q2 2024. 3,836 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • XTX Topco held 3,125 shares of Merck worth $402K as of Q2 2026.
  • XTX Topco sold 31,678 Merck shares in Q2 2026, an estimated $3.71M.
  • Merck made up 0.01% of XTX Topco's portfolio in Q2 2026, its #2655 holding.
  • XTX Topco first reported a position in Merck in Q1 2021 and has held it in 14 quarters since.
  • XTX Topco's Merck position peaked at $4.73M in Q2 2024.
  • 3,836 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on XTX Topco's 13F filing for Q2 2026, filed 14 Aug 2026.